Advertisement
Screener

VHCP Management II, LLC Current Holdings: USA Stocks

VHCP Management II, LLC current holdings: USA Stocks

VHCP Management II, LLC reported $0.05 billion in share positions in stocks (listed in the US), 6 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are BCRX, CTMX, HRTX.

  • BCRX: Country of operation United States; Class COM; Shares 5,721,142; Value $25,230,000.
  • CTMX: Country of operation United States; Class COM; Shares 577,831; Value $9,060,000.
  • HRTX: Country of operation United States; Class COM; Shares 405,901; Value $6,994,000.
  • RGNX: Country of operation United States; Class COM; Shares 332,494; Value $4,658,000.

Form 13F-HR as filed (SEC CIK 1602263): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.

Performance is each holding's price change from its close on the 2016-09-30 quarter end to its latest retained close (2026-09-29, or the date shown for a stock that stopped trading). Price only; dividends are not included. A stock that split in the period is restated by the split ratio in its own Form 8-K; a dash marks a holding with no retained closes.

StockCountry of operationClassSharesValue% of listedQuarter endFiledPerformance
BCRX
BioCryst Pharmaceuticals Inc
United StatesCOM5,721,142$25,230,00047.53%2016-09-302016-11-14— split 2019-05-21, ratio not on file
CTMX
CytomX Therapeutics Inc
United StatesCOM577,831$9,060,00017.07%2016-09-302016-11-14— split 2024-05-01, ratio not on file
HRTX
Heron Therapeutics Inc
United StatesCOM405,901$6,994,00013.18%2016-09-302016-11-14— split 2026-06-02, ratio not on file
RGNX
REGENXBIO Inc
United StatesCOM332,494$4,658,0008.78%2016-09-302016-11-14-46.82%
ONC
BeiGene Ltd
COM119,000$3,666,0006.91%2016-09-302016-11-14+1085.56%
CHRS
Coherus Biosciences Inc
United StatesCOM129,629$3,471,0006.54%2016-09-302016-11-14-95.59%

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet